Watanabe A, Nagashima H
First Department of Internal Medicine, Okayama University Medical School, Japan.
J Med. 1988;19(5-6):383-93.
Four pathophysiological types of hepatic failure suffered by 59 patients with liver cirrhosis were defined: chronic-recurrent type (Group A), acute exacerbation of chronic (Group B), post-operative type (Group C) and terminal type (Group D). The etiological, clinical and prognostic characteristics of the four types of hepatic failure were examined. More patients of Group C were seen in recent years than former years, but the opposite trend was observed in Group D. Direct causes or precipitating factors of hepatic failure differed depending upon the type of hepatic failure. Mortality rates were higher than 80% in the acute types of hepatic failure (Groups B, C and D), but were 50% in the chronic type (Group A). The association of multiple organ failure was frequently observed in Groups C (67%) and D (39%). Lactulose, nonabsorbable antibiotics and branched-chain amino acid solutions were used in combination for the treatment of patients of Groups A and D, with rates of arousal from encephalopathy of 75% and 29%, respectively. Even though further therapeutic maneuvers for acute hepatic failure were employed in Groups B and C, only low arousal rates of 38% and 27%, respectively, were obtained.
对59例肝硬化患者所患的四种病理生理类型的肝衰竭进行了定义:慢性复发性型(A组)、慢性急性加重型(B组)、术后型(C组)和终末期型(D组)。对这四种类型肝衰竭的病因、临床及预后特征进行了研究。近年来,C组患者较前几年增多,但D组则呈相反趋势。肝衰竭的直接病因或诱发因素因肝衰竭类型而异。急性肝衰竭类型(B组、C组和D组)的死亡率高于80%,而慢性类型(A组)为50%。C组(67%)和D组(39%)经常观察到多器官衰竭的关联。乳果糖、不吸收性抗生素和支链氨基酸溶液联合用于治疗A组和D组患者,脑病苏醒率分别为75%和29%。尽管对B组和C组的急性肝衰竭采用了进一步的治疗措施,但分别仅获得了38%和27%的低苏醒率。